» Articles » PMID: 24252658

Lipid Accumulation, Lipid Oxidation, and Low Plasma Levels of Acquired Antibodies Against Oxidized Lipids Associate with Degeneration and Rupture of the Intracranial Aneurysm Wall

Overview
Publisher Biomed Central
Specialty Neurology
Date 2013 Nov 21
PMID 24252658
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rupture of a saccular intracranial aneurysm (sIA) causes an often fatal subarachnoid hemorrhage (SAH). Why some sIAs rupture remains unknown. Since sIA walls bear some histological similarities with early atherosclerotic lesions, we hypothesized that accumulation and oxidation of lipids might occur in the sIA wall and might associate with sIA wall degeneration. Tissue samples from sIA fundi (n = 54) were studied with histochemistry and a panel of previously characterized antibodies for epitopes of oxidized LDL (OxLDL). Plasma samples from sIA carriers (n = 125) were studied with ELISA and EIA for IgG and IgM -antibodies against a panel of OxLDL epitopes.

Results: Lipid accumulation, foam cells, and oxidized lipids were found both in unruptured and ruptured sIA walls. Lipid accumulation associated with wall degeneration (P < 0.001), as did the expression of adipophilin, a marker of lipid ingestion by cells. Lipid accumulation associated also with loss of mural cells (P < 0.001), as did the accumulation of OxLDL (P < 0.001). Plasma IgG antibody titers against OxLDL or malondialdehyde modified LDL were higher in patients with unruptured sIAs than in patients with aneurysmal SAH (P ≤ 0.001). A trend but not statistically significant differences were found in plasma IgM antibodies against oxidized lipids.

Conclusions: Accumulation of lipids and their oxidation in the sIA wall associates with the degeneration of the sIA wall. Acquired immunity against oxidized lipid epitopes may be protective of lipid associated sIA wall degeneration, but warrants further studies.

Citing Articles

High levels of blood lipid and glucose predict adverse prognosis in patients with aneurysmal subarachnoid hemorrhage.

Yajun Z, Diqing O, Xingwei L, Liuyang T, Xiaofeng Z, Xiaoguo L Heliyon. 2024; 10(19):e38601.

PMID: 39397996 PMC: 11470529. DOI: 10.1016/j.heliyon.2024.e38601.


Risk factors and predictive indicators of rupture in cerebral aneurysms.

Wang X, Huang X Front Physiol. 2024; 15:1454016.

PMID: 39301423 PMC: 11411460. DOI: 10.3389/fphys.2024.1454016.


Early sexual activity lowers the incidence of intracranial aneurysm: a Mendelian randomization investigation.

Wu P, Akram P, Kadeer K, Aisha M, Cheng X, Wang Z Front Neurol. 2024; 15:1349137.

PMID: 38895700 PMC: 11184162. DOI: 10.3389/fneur.2024.1349137.


Pharmaceutical Modulation of Intracranial Aneurysm Development and Rupture.

Crane A, Shanahan R, Hudson J, Nowicki K, Gersey Z, Agarwal P J Clin Med. 2024; 13(11).

PMID: 38893035 PMC: 11173282. DOI: 10.3390/jcm13113324.


Current understanding of macrophages in intracranial aneurysm: relevant etiological manifestations, signaling modulation and therapeutic strategies.

Duan J, Zhao Q, He Z, Tang S, Duan J, Xing W Front Immunol. 2024; 14:1320098.

PMID: 38259443 PMC: 10800944. DOI: 10.3389/fimmu.2023.1320098.


References
1.
Ahmed E, Trifunovic J, Stegmayr B, Hallmans G, Lefvert A . Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study. Stroke. 1999; 30(12):2541-6. DOI: 10.1161/01.str.30.12.2541. View

2.
Kosierkiewicz T, Factor S, Dickson D . Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol. 1994; 53(4):399-406. DOI: 10.1097/00005072-199407000-00012. View

3.
Frosen J, Piippo A, Paetau A, Kangasniemi M, Niemela M, Hernesniemi J . Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke. 2004; 35(10):2287-93. DOI: 10.1161/01.STR.0000140636.30204.da. View

4.
Yla-Herttuala S, Palinski W, Butler S, Picard S, Steinberg D, Witztum J . Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994; 14(1):32-40. DOI: 10.1161/01.atv.14.1.32. View

5.
Binder C, Chang M, Shaw P, Miller Y, Hartvigsen K, Dewan A . Innate and acquired immunity in atherogenesis. Nat Med. 2002; 8(11):1218-26. DOI: 10.1038/nm1102-1218. View